Related references
Note: Only part of the references are listed.Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer Related Targets
Ziga Skok et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of a D-pro-lys peptidomimetic inhibitor of MMP9: Addressing the gelatinase selectivity beyond S1′ subsite
Elena Lenci et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
Tijana Stankovic et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Identification of highly potent and selective MMP2 inhibitors addressing the subsite S1' with D-proline-based compounds
Elena Lenci et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
Gregg B. Fields
FRONTIERS IN IMMUNOLOGY (2019)
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
Gregg B. Fields
CELLS (2019)
Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects
Andrea Angeli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells
Jia-Sin Yang et al.
ONCOTARGET (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII
Srinivas Angapelly et al.
CHEMMEDCHEM (2017)
Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors
Andrea Angeli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective
Ying Hong Li et al.
PLOS ONE (2016)
A study of a D-proline peptidomimetic inhibitor of melanoma and endothelial cell invasion through activity towards MMP-2 and MMP-9
Francesca Bianchini et al.
MEDCHEMCOMM (2015)
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors
Marilena Tauro et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
New approaches to selectively target cancer-associated matrix metalloproteinase activity
Marilena Tauro et al.
CANCER AND METASTASIS REVIEWS (2014)
Polypharmacology: Challenges and Opportunities in Drug Discovery
Andrew Anighoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
D-Proline-based peptidomimetic inhibitors of anthrax lethal factor
Chiara Calugi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Carbamoylphosphonates Control Tumor Cell Proliferation and Dissemination by Simultaneously Inhibiting Carbonic Anhydrase IX and Matrix Metalloproteinase-2. Toward Nontoxic Chemotherapy Targeting Tumor Microenvironment
Reuven Reich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
Paul C. McDonald et al.
ONCOTARGET (2012)
In Vitro Inhibition of Human Carbonic Anhydrase I and II Isozymes with Natural Phenolic Compounds
Murat Senturk et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Carbonic anhydrase inhibitors and activators for novel therapeutic applications
Claudiu T. Supuran
FUTURE MEDICINAL CHEMISTRY (2011)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Structural and functional bases for allosteric control of MMP activities: Can it pave the path for selective inhibition?
Netta Sela-Passwell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors
M. Alexandra Esteves et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors
Seppo Parkkila et al.
MODERN PATHOLOGY (2010)
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: Synthesis and bioactivity
Domenica Torino et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Selective Matrix Metalloproteinase Inhibitors for Cancer
Nian-Guang Li et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Carbonic anhydrases - An overview
Claudiu T. Supuran
CURRENT PHARMACEUTICAL DESIGN (2008)
Progress in matrix metalloproteinase research
Gillian Murphy et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Carbonic anhydrases as targets for medicinal chemistry
Claudiu T. Supuran et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Matrix metalloproteinases as valid clinical targets
Barbara Fingleton
CURRENT PHARMACEUTICAL DESIGN (2007)
Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions
Samuel Varghese
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Carbonic anhydrase inhibitors.: Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors
A Cecchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Matrix metalloproteinases as therapeutic targets in cancer
P Vihinen et al.
CURRENT CANCER DRUG TARGETS (2005)
Tangible interfaces for structural molecular biology
A Gillet et al.
STRUCTURE (2005)
Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX
JR Casey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
VEGA - An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming
A Pedretti et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2004)
A bioinorganic perspective on matrix metalloproteinase inhibition
DT Puerta et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Carbonic anhydrase inhibitors
CT Supuran et al.
MEDICINAL RESEARCH REVIEWS (2003)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Metalloproteinases in biology and pathology of the nervous system
VW Yong et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Carbonic anhydrase and matrix metalloproteinase inhibitors:: Sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes
A Scozzafava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis
SJ George
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Share Paper
